A Phase II Study of Combining T-VEC NSC-785349 and Pembrolizumab NSC-776864 in Patients with Advanced Melanoma Who Have Progressed on Anti-PD1/L1 Based Therapy
International Phase 3 Trial in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Ph+ALL Testing Imatinib in Combination with Two Different Cytotoxic Chemotherapy Backbones
Phase II Trial of Intravesical Gemcitabine and MK-3475 Pembrolizumab in the Treatment of Patients with BCGUnresponsive Non-Muscle Invasive Bladder Cancer
A Phase I, Open-Label, Multi-Center, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Anti-Tumor Activity of The WEE1 Inhibitor IMP7068 Monotherapy in Patients with Advanced Solid Tumors
A Phase III, Randomized, Double-blind Study of Encorafenib and Binimetinib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab in Previously Untreated BRAF V600E/K Mutation-Positive Participants with Unresectable or Metastatic Melanoma. STARBOARD
An Open-label, Multicenter, Multicohort, Phase II Study to Evaluate Enfortumab Vedotin in Subjects with Previously Treated Locally Advanced or Metastatic Malignant Solid Tumors EV-202